Nine Square Therapeutics
CA - South SFBiotechnology
Focus: Nine Square Therapeutics is a small-molecule biotech focused on neurology and related therapeutic areas, headquartered in South San Francisco. The company operates primarily in the generic/ANDA space with established marketed products.
Profile data last refreshed 16m ago · AI intelligence enriched 3w ago
Open Jobs
0
About Nine Square Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Nine Square Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Nine Square Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
Post-LOE
Atypical antipsychotic ANDA product; post-LOE market suggests pricing/volume pressure in competitive psychiatric generics space.
Help build intelligence for Nine Square Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.